Login / Signup

Sodium channel-inhibiting drugs and cancer-specific survival: a population-based study of electronic primary care data.

Caroline FairhurstFabiola MartinIan WattMartin BlandTim DoranWilliam John Brackenbury
Published in: BMJ open (2023)
Association between VGSC inhibitor use and mortality in patients with cancer varies according to indication. Exposure to VGSC-inhibiting antiarrhythmics, but not anticonvulsants, supports findings from preclinical data, with improved survival. However, additional confounding factors may underlie these associations, highlighting the need for further study.
Keyphrases
  • primary care
  • electronic health record
  • signaling pathway
  • big data
  • papillary thyroid
  • cardiovascular events
  • squamous cell
  • risk factors
  • stem cells
  • young adults
  • childhood cancer